On Monday, Zenas Biopharma Inc (NASDAQ: ZBIO) was 6.84% up from the session before settling in for the closing price of $35.8. A 52-week range for ZBIO has been $5.83 – $38.50.
When this article was written, the company’s average yearly earnings per share was at 65.48%. With a float of $13.21 million, this company’s outstanding shares have now reached $42.21 million.
Zenas Biopharma Inc (ZBIO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zenas Biopharma Inc stocks. The insider ownership of Zenas Biopharma Inc is 75.39%, while institutional ownership is 31.10%. The most recent insider transaction that took place on Oct 09 ’25, was worth 1,200,002. In this transaction Director of this company bought 63,158 shares at a rate of $19.00, taking the stock ownership to the 1,173,395 shares. Before that another transaction happened on Oct 09 ’25, when Company’s 10% Owner bought 126,315 for $19.00, making the entire transaction worth $2,399,985. This insider now owns 1,917,895 shares in total.
Zenas Biopharma Inc (ZBIO) Latest Financial update
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
You can see what Zenas Biopharma Inc (ZBIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 136.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.53, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -4.19 in one year’s time.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Zenas Biopharma Inc (NASDAQ: ZBIO) saw its 5-day average volume 0.36 million, a positive change from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 64.51%.
During the past 100 days, Zenas Biopharma Inc’s (ZBIO) raw stochastic average was set at 99.14%, which indicates a significant increase from 97.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.74 in the past 14 days, which was higher than the 1.98 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.17, while its 200-day Moving Average is $15.27. Nevertheless, the first resistance level for the watch stands at $39.11 in the near term. At $39.97, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.53. If the price goes on to break the first support level at $36.69, it is likely to go to the next support level at $35.13. The third support level lies at $34.27 if the price breaches the second support level.
Zenas Biopharma Inc (NASDAQ: ZBIO) Key Stats
There are 53,679K outstanding shares of the company, which has a market capitalization of 2.05 billion. As of now, sales total 5,000 K while income totals -156,990 K. Its latest quarter income was 0 K while its last quarter net income were -52,220 K.
